Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

300760.SZ

300760.SZShenzhen Mindray Bio-Medical Electronics Co., Ltd. CN flag

Shenzhen Stock Exchange

214.65

CNY

-0.41

(-0.19%)

9.18EPS

23.38P/E

259.85BMarket Cap

Aug 30Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

CNE100003G67

Return %

Stock

S&P500

-21.03

10.14

-30.76

62.89

-35.09

93.94

Use logarithmic scale

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	8.47	8.63	9.09	10.23	12.35	13.62	17.3	20.8	25.1	28.83	30.33	29.38
Basic EPS, GAAP	1.47	0.98	1.61	2.37	3.34	3.85	5.48	6.59	7.94	9.56	9.64	9.19
Free Cash Flow per Basic Share	-0.64	1.54	2.64	2.59	3.01	3.25	6.32	6.25	8.45	6.91	8.65	-1.7
Dividend per Share	0.05	3.69	6.56	0.56	0.85	1	1.5	2.5	3.5	8.81	7.22	7.22
Book Value per Share	9.06	6.36	1.4	3.19	5.7	8.07	12.04	16.14	20.64	21.37	23.81	25.97
Tangible Book Value per Share	7.75	4.67	2.29	4.01	11.45	13.33	17.07	16.92	20.93	21.22	18.65	20.94
Basic Weighted Avg Shares	925	928	994	1,092	1,114	1,216	1,216	1,215	1,210	1,212	1,211	1,211
Sales/Revenue/Turnover	7,836	8,013	9,032	11,174	13,753	16,556	21,026	25,270	30,366	34,932	36,726	35,590
Operating Margin (%)	14.34	12.14	16.85	29.33	30.37	31.03	35.86	35.98	35.13	36.98	35.53	35.26
Depreciation Expense	- -	316	285	304	331	394	472	700	885	1,010	1,469	- -
Net Income, GAAP	1,360	910	1,600	2,589	3,719	4,681	6,658	8,002	9,607	11,582	11,668	11,137
Effective Tax Rate (%)	4.21	13.68	12.93	11.26	12.09	12.73	10.47	11.23	12.26	11.01	9.83	9.95
Profit Margin (%)	17.35	11.35	17.72	23.17	27.04	28.27	31.66	31.66	31.64	33.16	31.77	31.29
Working Capital	6,019	1,959	1,735	2,355	10,662	13,505	13,328	12,706	18,836	16,773	15,219	16,569
LT Debt	1,202	311	1,678	- -	- -	- -	122	152	139	182	178	182
Total Equity	9,662	6,538	4,601	6,654	15,167	18,607	23,290	26,968	31,999	33,346	40,758	43,558
Return on Invested Capital (%)	- -	8.42	15.72	34.49	30.5	26.16	31.76	31.46	31.05	34.5	31.2	27.61
Return on Capital (%)	- -	10.01	25.39	51.06	63.94	57.73	53.97	46.16	42.65	44.84	38.35	33.19
Return on Common Equity (%)	- -	12.73	43.84	106.22	75.66	57.94	54.47	46.74	43.11	45.54	42.64	36.81

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	16.97%	17.51%	5.14%
Net Income, GAAP	27.79%	20.76%	0.74%
Free Cash Flow	-7.98%	27.05%	25.07%
Total Cash Common Dividend	780.93%	57.99%	-18.06%
Total Equity	21.94%	17.21%	22.23%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Hao Wu
Full Time Employees: 21,667
Sector: Healthcare
Industry: Medical - Devices
Address: Mindray Building Shenzhen People's Republic of China 518057
IPO Date: Oct 16, 2018
Website: mindray.com
Similar Companies: Sino Medical Sciences Technology Inc. (688108.SS)
Value Added Technology Co., Ltd. (043150.KQ)
Medical Supply International USA, Inc. (MSIU)
Nano-X Imaging Ltd. (NNOX)
Medigus Ltd. (MDGS)
PolyNovo Limited (PNV.AX)
Business: Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions worldwide. The company offers patient monitoring and life support products, such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, endoscopes, and accessories, as well as emergency care, peri-operative care, critical care, and IT solutions. It also provides in-vitro diagnostics products, including hematology and chemistry analyzers and reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry products, and micro plate readers and washers, as well as coagulation, urinalysis, and microbiology solutions; medical imaging systems comprising ultrasound and radiology products; and veterinary products. The company was founded in 1991 and is headquartered in Shenzhen, the People's Republic of China.

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	8.47	8.63	9.09	10.23	12.35	13.62	17.3	20.8	25.1	28.83	30.33	29.38
Basic EPS, GAAP	1.47	0.98	1.61	2.37	3.34	3.85	5.48	6.59	7.94	9.56	9.64	9.19
Free Cash Flow per Basic Share	-0.64	1.54	2.64	2.59	3.01	3.25	6.32	6.25	8.45	6.91	8.65	-1.7
Dividend per Share	0.05	3.69	6.56	0.56	0.85	1	1.5	2.5	3.5	8.81	7.22	7.22
Book Value per Share	9.06	6.36	1.4	3.19	5.7	8.07	12.04	16.14	20.64	21.37	23.81	25.97
Tangible Book Value per Share	7.75	4.67	2.29	4.01	11.45	13.33	17.07	16.92	20.93	21.22	18.65	20.94
Basic Weighted Avg Shares	925	928	994	1,092	1,114	1,216	1,216	1,215	1,210	1,212	1,211	1,211
Sales/Revenue/Turnover	7,836	8,013	9,032	11,174	13,753	16,556	21,026	25,270	30,366	34,932	36,726	35,590
Operating Margin (%)	14.34	12.14	16.85	29.33	30.37	31.03	35.86	35.98	35.13	36.98	35.53	35.26
Depreciation Expense	- -	316	285	304	331	394	472	700	885	1,010	1,469	- -
Net Income, GAAP	1,360	910	1,600	2,589	3,719	4,681	6,658	8,002	9,607	11,582	11,668	11,137
Effective Tax Rate (%)	4.21	13.68	12.93	11.26	12.09	12.73	10.47	11.23	12.26	11.01	9.83	9.95
Profit Margin (%)	17.35	11.35	17.72	23.17	27.04	28.27	31.66	31.66	31.64	33.16	31.77	31.29
Working Capital	6,019	1,959	1,735	2,355	10,662	13,505	13,328	12,706	18,836	16,773	15,219	16,569
LT Debt	1,202	311	1,678	- -	- -	- -	122	152	139	182	178	182
Total Equity	9,662	6,538	4,601	6,654	15,167	18,607	23,290	26,968	31,999	33,346	40,758	43,558
Return on Invested Capital (%)	- -	8.42	15.72	34.49	30.5	26.16	31.76	31.46	31.05	34.5	31.2	27.61
Return on Capital (%)	- -	10.01	25.39	51.06	63.94	57.73	53.97	46.16	42.65	44.84	38.35	33.19
Return on Common Equity (%)	- -	12.73	43.84	106.22	75.66	57.94	54.47	46.74	43.11	45.54	42.64	36.81

	Sep'24	Dec'24	Mar'25
ST Debt	121	121	118
LT Borrowings	- -	- -	- -
LT Finance Leases	179	177	182
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	1,212	1,212	1,212
Market Capitalization	354,637	308,643	283,477

	Sep'24	Dec'24	Mar'25
Total Current Assets	27,103	25,647	27,310
Accounts Receivable, Net	3,604	3,219	3,481
Cash, Cash Equivalents & STI	17,660	16,644	17,711
Inventories	4,857	4,757	5,173
Total Current Liabilities	11,559	10,427	10,741
Payables & Accruals	- -	- -	- -
ST Debt	121	121	118
Deferred Revenue	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2023	8,364	10,111	8,828	7,628	34,932
2024	9,373	11,158	8,954	7,241	36,726
2025	8,237	- -	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2023	2.13	- -	- -	- -	9.56
2024	2.61	- -	- -	- -	9.64
2025	2.17	- -	- -	- -	- -

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Quarterly Revenue

Year

Quarterly Earnings Per Share

Year

Quarterly Dividends Per Share

Year